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Vitamin A has an essential role in vision in that it forms the photosensitive pigments that absorb 
light and initiate the visual process. However, vitamin A and its analogues also have critical roles 
in maintaining the structural integrity of the retina. Disruption of the metabolism of vitamin A 
results in several blinding diseases. This review focuses on our recent studies on the role of a 
protein critical to the processing of vitamin A, RPE65. The absence or dysfunction of this protein 




Vitamin A is a fat soluble alcohol essential for normal growth, 
development and reproduction. The structure for vitamin A 
(all-trans retinol 1), with other retinoids discussed here, are 
shown in Figure 1. This vitamin is also essential for vision, as 
it is the precursor to the molecule (11-cis retinal 3), that forms 
the pigments in the eye that absorb light [1]. Indeed, the first 
sign of vitamin A deficiency is night blindness, that is, a 
failure to see under dim light conditions. Vitamin A 
deficiency is rarely seen in developed countries as the vitamin 
in readily available from the carotenoids, such as ββ-carotene 
2, found in a healthy diet. However, it is a problem in 
underdeveloped countries. There are innovative programs 
genetically introducing carotenoids into rice, which is 
consumed in great quantities in many of these countries [2].  
 
The eye 
The eye contains the photosensitive cells that convert light 
into neuronal signals, and these cells are found in the retina, 
which is at the back of the eye (Fig. 2). There are two families 
of these photosensitive cells: rods and cones. Rods 
mediatedim-light vision, and cones mediate color and bright-
light vision. In the human retina, the distribution patterns of 
rods and cones differ: rods are found throughout the retina 
except for a tiny central area (0.22 mm in diameter) named the 
fovea, but cones are localized mainly within the fovea to 
mediate high-acuity central vision. Although both classes of 
photoreceptors contribute to sight, humans exhibit a far 
greater dependence on the cones for daily activity. Eye 
diseases that result in cone death within the fovea lead to the 
loss of central vision and a severe detriment to the quality of 
life of the individual. Although the relationship of night 
blindness to vitamin-A deficiency was recognized many years 
ago [1], the understanding that many eye disorders, 
particularly those involving retinal degeneration, are caused 
by some malfunction of the retinoid cycle is relatively recent. 
For a recent review see Kiser et al. [3]. The purpose of our 
research has been to understand this cycle and to study 
specific areas where the process fails. Our recent studies on 
one of these key components, RPE65, are here discussed.  
 
The retinoid cycle 
The role of the retinoid cycle is to supply the photoreceptors 













Figure 1. Retinoids important in the visual process: 1, all-trans retinol 





Figure 2. The vertebrate retina and rod and cone photoreceptors. (A) The 
left panel is a cross section of a mouse eye illustrating the retina located in 
the posterior portion eye (left);  increasing the magnification shows that 
the retina is organized into multiple distinct layers (right). (B) Schematic 
of a vertebrate rod and cone photoreceptor cell. RPE = retina pigment 
epithelium; OS = outer segment; IS = inner segment; ONL = outer 
nuclear layer; OPL = outer plexiform layer; INL = inner nuclear layer; 
IPL = inner plexiform layer; GCL = ganglion cell layer. (Reprinted with 
permission from [5]; Progress in Retinal Eye Research is the copyright 
holder.) 
 
essential for the formation of the photosensitive pigments that 
detect light. This isomeric form is extremely reactive and hard 
to synthesize in a test tube. There are many steps in the 
process and the mechanism is still not fully understood. The 
11-cis retinal forms a covalent bond with the pigment 
apoprotein (opsin) specific to that photoreceptor and the 
resulting pigment is then light sensitive. The light sensitivity 











Figure 3. Retinoid cycles for rods and cones. The  rods depend solely on 
the retina pigment epithelium (RPE) cycle for 11-cis retinal (11-cis RAL). 
The cones depend on both the RPE and the intraretinal cycles. RE = 
retinyl-ester; REH = retinyl ester hydrolase; RDH = retinol 
dehydrogenase; RAL = retinal; ROL = retinol; LRAT = lecithin-retinol 
acyltransferase; IRBP = interphotoreceptor retinoid binding protein; 
ARAT = acyl CoA-retinol acyltransferase. (Reprinted with permission 
from [8]; Journal of Neuroscience is the copyright holder.) 
 
humans, there are three cone opsins and one rod opsin. The 
absorption of a photon causes an isomerization of the 11-cis 
bond to the trans form, all-trans retinal 4 (Fig. 1), activating 
the opsin protein, which is a G- protein coupled receptor, and 
initiating the visual process. The retinoid cycles for both rods 
and cones are outlined in Figure 3. For many years it was 
believed that a single cycle operated for both. However, the 
need for 11-cis retinal by the two classes of photoreceptors is 
different. The cones function under bright light conditions and 
need a constant, immediately available supply of the critical 
11-cis retinal. The rods have a much slower process. Studies 
by many groups have resulted in the understanding that the 
classical retinoid process proceeding through the retinal 
pigment epithelium is not adequate to supply both the cone 
and the rod processes. The cones depend on both cycles, 
whereas the rods use only the rod cycle (for recent reviews, 
see Kiser et al. [3], Sari [4] Tang et al. [5]).  
 
RPE65 
The critical step in the visual process is the formation of the 
photosensitive pigments and this requires 11-cis retinal. 
RPE65 is an abundant protein in the retinal pigment 
epithelium. Its function was unknown, but when an animal 
model which was missing the protein was studied, it was 
recognized that no 11-cis retinal was being generated [6]. 
Thus, this protein is an essential component of the complex 
that isomerizes the all-trans form of retinal to the 11-cis form. 
The exact mechanism is still not fully elucidated, but RPE65 
is key to the process of generating 11-cis retinal by the retinal 
pigment epithelium. It was initially proposed that RPE65 is a 
protein specific to the retinal pigment epithelium. However,  
our group has identified the protein in the cones from several 
species (Fig. 4) [7] and recently in the human cones (Fig. 5) 
[8]. The protein is in the outer segment of the cones and 
unlikely to have a direct role in the isomerization process. Our 
studies support a role as a retinoid binding protein, possibly 
promoting hydrolysis of the 11-cis ester. 
The role of RPE65 in humans 
Mutations of the RPE65 protein are known to result in a 
childhood blinding disease, Leber congenital amaurosis Type 
2 (LCA2) [9]. These mutations impair the ability of the 
RPE65 protein to generate 11-cis retinal and degeneration of 
the retina occurs. Animal studies gave us the unexpected 
finding that the cones actually degenerate more rapidly than 
Figure 4. Lack of RPE65 results in visual pigment mislocalization 
in cones. Co-localization in cone photoreceptors of cross-
sectioned, post-natal day 21, Rpe65-/-Rho-/- retinas. (A) Untreated 
mice; (B) 11-cis retinal-treated mice maintained in the dark; (C) 
11-cis retinal-treated mice maintained in 12 hours light/12 hours 
dark conditions. The sections were stained with antibody for the 
mouse S cone opsin (red).. The locations of the photoreceptor 
outer segment (OS), photoreceptor inner segment (IS), outer 
nuclear layer (ONL) and outer plexiform layer (OPL). The scale 
bar represents 20 μm. (Reprinted with permission from [7]; 
Investigative Ophthalmology and Visual Science is the copyright 
holder.) 
 
Figure 5. Localization of RPE65 in human cones. Cones are
visualized by immunostaining for cone arrestin (CAR) in red.
RPE65 is immunostained in green and found to be co-localized
within the outer segment (yellow). (A) RPE65 staining alone in the
same cone appears green. Images are acquired from sections
prepared from a young donor eye (age 11 years). Scale bar = 10
µm. (Reprinted with permission from [8]; Journal of Neuroscience
is the copyright holder.) 
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the rods in the absence of RPE65. We found this to be due to 
the mistrafficking of the cone visual pigment proteins (Fig. 5) 
[10]. This can be corrected by the administration of 11-cis 
retinal, but only if the animals are kept in the dark [11]. 
Interestingly, the cone opsins apparently require 11-cis retinal 
to move the opsin into the outer segment, while the rods do 
not. The purpose of our recent studies has been to understand 
the protein RPE65 and its involvement in promoting cone 
visual function in humans. The results of these studies have 
clinical implications for the treatment of Leber congenital 
amauros Type 2. This disease has been the focus of much 
attention as successful gene therapy to replace the defective 
Rpe65 gene has been accomplished [12, 13]. However, for 
patients to have useful vision, early degeneration of cones 
must be prevented so that when the protein is introduced, the 
patients can function under normal daylight. Challenges 
certainly remain for the future. 
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